279 related articles for article (PubMed ID: 9140266)
1. Triglycerides and coronary risk in women and the elderly.
LaRosa JC
Arch Intern Med; 1997 May; 157(9):961-8. PubMed ID: 9140266
[TBL] [Abstract][Full Text] [Related]
2. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
3. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
Grundy SM; Vega GL
Arch Intern Med; 1992 Jan; 152(1):28-34. PubMed ID: 1728925
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
5. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
6. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
7. A risk factor for atherosclerosis: triglyceride-rich lipoproteins.
Malloy MJ; Kane JP
Adv Intern Med; 2001; 47():111-36. PubMed ID: 11795072
[TBL] [Abstract][Full Text] [Related]
8. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
9. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
Rajmohan L; Deepa R; Mohan A; Mohan V
Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
[TBL] [Abstract][Full Text] [Related]
10. Hypertriglyceridemia: management of atherogenic dyslipidemia.
Bersot T; Haffner S; Harris WS; Kellick KA; Morris CM
J Fam Pract; 2006 Jul; 55(7):S1-8. PubMed ID: 16822443
[TBL] [Abstract][Full Text] [Related]
11. Lipids as a coronary risk factor: analysis of hyperlipidaemias.
Hamsten A
Postgrad Med J; 1993; 69 Suppl 1():S8-11. PubMed ID: 8497457
[TBL] [Abstract][Full Text] [Related]
12. An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic -- relevance to high-carbohydrate diets.
McCarty MF
Med Hypotheses; 2004; 63(6):1065-73. PubMed ID: 15504577
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
14. The emergence of triglycerides as a significant independent risk factor in coronary artery disease.
Assmann G; Schulte H; Funke H; von Eckardstein A
Eur Heart J; 1998 Oct; 19 Suppl M():M8-14. PubMed ID: 9821011
[TBL] [Abstract][Full Text] [Related]
15. Management of hypertriglyceridemia.
Oh RC; Lanier JB
Am Fam Physician; 2007 May; 75(9):1365-71. PubMed ID: 17508532
[TBL] [Abstract][Full Text] [Related]
16. Role of circulating high-density lipoprotein and triglycerides in coronary artery disease: risk and prevention.
Gordon DJ
Endocrinol Metab Clin North Am; 1990 Jun; 19(2):299-309. PubMed ID: 2192875
[TBL] [Abstract][Full Text] [Related]
17. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.
Eberly LE; Stamler J; Neaton JD;
Arch Intern Med; 2003 May; 163(9):1077-83. PubMed ID: 12742806
[TBL] [Abstract][Full Text] [Related]
18. [Triglyceride-rich lipoproteins and risk of atherosclerotic cardiovascular diseases in various European populations].
Rubba P; De Simone B; Pauciullo P
Klin Wochenschr; 1990; 68 Suppl 22():59-62. PubMed ID: 2087081
[TBL] [Abstract][Full Text] [Related]
19. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
[TBL] [Abstract][Full Text] [Related]
20. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
Karalis DG; Ishisaka DY; Luo D; Ntanios F; Wun CC
Am J Cardiol; 2007 Aug; 100(3):445-9. PubMed ID: 17659926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
